ZQK, CRWE, GNMK, RAX - CRWEPicks.com Stock Highlights! Quiksilver, Crown Equity Holdings, GenMark Diagnostics, Rackspace Hosting
(SSI, GNMK, CRWE, PIR) BestOTC.com Stock Market Activity
(CRWE, PIR, ACTG, GNMK) CRWEWallStreetNewsAlert.com Stock Report from Wall Street
(GVP, GNMK, POWR) PennyOmega.com Watch List for Friday Mar. 09, 2012
NHPR.OB, PCOM, CRWE.OB, RSYS, GNMK, - CRWESelect.com Stock Report! National Health Partners, Points International
NHPR, GNMK, CRWE, NPSP, BCRX - Stock News and Highlights From DoubleInStocks.com
NPS Pharmaceuticals, Inc. (Nasdaq:NPSP) announced the randomization of the last patient in REPLACE, its Phase 3 registration study of NPSP558, a bioengineered form of human parathyroid hormone. REPLACE was a double-blind, placebo-controlled study evaluating the use of NPSP558 as hormone replacement therapy in adult patients with hypoparathyroidism.